Chemours director granted deferred stock units

Chemours Co director Courtney Mather received a grant of deferred stock units as part of board compensation.

Rhea-AI Filing Summary

Chemours Co director Courtney Mather received a grant of deferred stock units as part of board compensation. On this date, Mather acquired 1,401 deferred stock units, each economically equivalent to one share of Chemours common stock, at a reference value of $20.52 per unit.

The award increases Mather’s directly held deferred stock units to a total of 8,983.8481 units, including dividend equivalent units. These deferred stock units become payable in shares of common stock in the first month after Mather’s termination of service as a director, so they function as long-term, non-cash compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 1,401 shares

Grant/Award 1 txn

Insider MATHER COURTNEY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	1,401	$20.52	$29K

Holdings After Transaction: Deferred Stock Units — 8,983.8481 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reporting Person's termination of service as a director.
2. F2. Includes deferred stock units and dividend equivalent units.

Key Figures

Deferred stock units granted: 1,401 units Reference price per unit: $20.52 per unit Total deferred stock units after grant: 8,983.8481 units +1 more

4 metrics

Deferred stock units granted 1,401 units Grant of deferred stock units to director on 2026-06-30

Reference price per unit $20.52 per unit Value used for deferred stock unit award

Total deferred stock units after grant 8,983.8481 units Director’s deferred stock unit balance following the transaction

Underlying common stock shares 1,401 shares Common stock underlying the new deferred stock units

Key Terms

Deferred Stock Units, dividend equivalent units, Grant, award, or other acquisition

3 terms

Deferred Stock Units financial

"Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

dividend equivalent units financial

"Includes deferred stock units and dividend equivalent units."

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Chemours (CC) director Courtney Mather report?

Courtney Mather reported receiving 1,401 deferred stock units as compensation. These units are economically equivalent to Chemours common shares and increase total deferred holdings to 8,983.8481 units, functioning as long-term equity-based pay rather than an open-market stock purchase.

Is Courtney Mather’s Form 4 transaction in Chemours (CC) a stock purchase or a grant?

The Form 4 shows a grant, not an open-market purchase. Mather received 1,401 deferred stock units as a compensation-related award, coded as an acquisition (A), increasing total deferred stock unit holdings to 8,983.8481 units tied to Chemours common stock.

How do Chemours (CC) deferred stock units work for director Courtney Mather?

Each deferred stock unit is economically equivalent to one Chemours common share. The units, including dividend equivalent units, become payable in the first month after Mather’s termination as a director, providing long-term equity exposure instead of immediate cash or tradable shares.

When will Courtney Mather receive Chemours (CC) shares from these deferred stock units?

The deferred stock units become payable after board service ends. Specifically, Chemours will deliver the equivalent common shares in the first month following Mather’s termination as a director, turning the accumulated 8,983.8481 units into actual share delivery at that time.

How many Chemours (CC) deferred stock units does Courtney Mather hold after this grant?

After receiving 1,401 new deferred stock units, Mather holds 8,983.8481 units in total. This figure includes both the newly granted units and dividend equivalent units, all economically equivalent to Chemours common shares and payable after board service ends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATHER COURTNEY

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	06/30/2026		A		1,401		(1)	(1)	Common Stock	1,401	$20.52	8,983.8481(2)	D

Explanation of Responses:

1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reporting Person's termination of service as a director.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)